Search for: "Lilly"
Results 2341 - 2360
of 3,231
Sorted by Relevance
|
Sort by Date
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
31 Mar 2016, 6:40 am
" Dr Peters, who also writes a column for Medscape Diabetes & Endocrinology, has served as a speaker or consultant with Eli Lilly, Boehringer Ingelheim Pharmaceuticals, and AstraZeneca Pharmaceuticals, which make SGLT-2 inhibitors. [read post]
16 Jul 2012, 10:17 am
In Eli Lilly & Co. v. [read post]
23 Feb 2011, 9:49 am
Eli Lilly & Co., 598 F.3d 1336, 1354 (Fed. [read post]
5 May 2015, 12:12 pm
Returning to his thesis, McMahon pointed out that this was hardly Nixon’s intention, and was rather a by-product of the failure of the Friday and Lillie nominations. [read post]
23 Mar 2010, 6:00 am
Eli Lilly and Co., pp. 12, 26. [read post]
16 Jul 2015, 4:00 am
This addresses a problem seen, for example, in the decision in Lilly Icos LLC v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
7 Aug 2012, 5:02 pm
Eli Lilly and Company, et al., Civil Action No. 2:12-66). [read post]
2 Nov 2011, 4:53 am
Meanwhile, the Respondent [Eli Lilly] brought parallel proceedings in the High Court for revocation of the Patent in the UK. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly (EPLAW)… [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell limits on… [read post]
23 Sep 2020, 6:16 am
If you’d like to imagine Ginsburg-the-writer unconstrained, start with the dissent she read from the bench in the Lilly Ledbetter unequal-pay case. [read post]
7 Dec 2016, 11:58 pm
Claire referred to the HGS v Lilly [2011] UKSC 51 and Actavis v Lilly [2015] EWHC 3294 (Pat) cases as examples of patents which did not have data in them and yet were found to be plausible. [read post]
19 Dec 2019, 9:41 am
In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
7 Nov 2014, 5:52 am
Eli Lilly & Co., 394 F. [read post]
14 Oct 2015, 10:21 am
Larry Welch (Eli Lilly)Larry Welch from Eli Lilly concluded the presentation by outlining the position under US law which is simple - there is no requirement to remunerate inventors under US law. [read post]
4 Feb 2019, 2:01 am
The new year sees the issue of yet another UK court case applying the doctrine of equivalents as established by the UK Supreme Court in Actavis v Eli Lilly ([2017] UKSC 48) ("Actavis"). [read post]
